Molecular imaging: Techniques and current clinical applications

[1]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[2]  A. Iagaru,et al.  Breast MRI and 18F FDG PET/CT in the management of breast cancer. , 2007, Annals of nuclear medicine.

[3]  S. Kasper,et al.  Genetically modified mice and their use in developing therapeutic strategies for prostate cancer. , 2004, The Journal of urology.

[4]  Hideo Tsukada,et al.  Amyloid imaging in aged and young macaques with [11C]PIB and [18F]FDDNP , 2008, Synapse.

[5]  C. Solbach,et al.  Efficient radiosynthesis of carbon-11 labelled uncharged Thioflavin T derivatives using [11C]methyl triflate for beta-amyloid imaging in Alzheimer's Disease with PET. , 2005, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[6]  G. Curran,et al.  Targeting Alzheimer amyloid plaques in vivo , 2000, Nature Biotechnology.

[7]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[8]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[9]  H. Arai,et al.  Recent advances in the development of amyloid imaging agents. , 2007, Current topics in medicinal chemistry.

[10]  P. Dupont,et al.  18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact , 2002, Melanoma research.

[11]  M. Sasaki,et al.  A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours , 1998, European Journal of Nuclear Medicine.

[12]  W. Koch,et al.  Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  F. Mottaghy,et al.  Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humans , 2007, Nuklearmedizin.

[14]  Isabelle Salmon,et al.  Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Brian J Bacskai,et al.  A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. , 2002, Bioorganic & medicinal chemistry letters.

[16]  M. Thakur,et al.  99mTc-Fanolesomab: affinity, pharmacokinetics and preliminary evaluation. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[17]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[18]  Koji Murakami,et al.  PET/CT supports breast cancer diagnosis and treatment , 2008, Breast cancer.

[19]  M. Morino,et al.  Magnetic resonance imaging and [11C]methyl-L-methionine positron emission tomography of fibrous dysplasia--two case reports. , 2002, Neurologia medico-chirurgica.

[20]  M. Senda,et al.  A comparative study on protein incorporation of L-[methyl-3H]methionine, L-[1-14C]leucine and L-2-[18F]fluorotyrosine in tumor bearing mice. , 1993, Nuclear medicine and biology.

[21]  Ming-Rong Zhang,et al.  [18F]Fluoroalkyl agents: synthesis, reactivity and application for development of PET ligands in molecular imaging. , 2007, Current topics in medicinal chemistry.

[22]  Chunying Wu,et al.  Amyloid imaging: from benchtop to bedside. , 2005, Current topics in developmental biology.

[23]  A. Tanimoto,et al.  Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide , 1994, Journal of magnetic resonance imaging : JMRI.

[24]  M. Morino,et al.  Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery —In malignant glioma— , 2004, Annals of nuclear medicine.

[25]  M. O'Doherty,et al.  [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  D. Skovronsky,et al.  Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  A. Pathak,et al.  Magnetic resonance imaging and spectroscopy of transgenic models of cancer , 2007, NMR in biomedicine.

[28]  Takako Yamaguchi,et al.  The Roles of PET and PET/CT in the Diagnosis and Management of Prostate Cancer , 2008, Oncology.

[29]  Vasilis Ntziachristos,et al.  Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Schmitz.  Ultrasonic imaging of molecular targets , 2008, Basic Research in Cardiology.

[31]  Alan P. Koretsky,et al.  Magnetic resonance imaging of the migration of neuronal precursors generated in the adult rodent brain , 2006, NeuroImage.

[32]  A. Hampl,et al.  In vitro labelling of mouse embryonic stem cells with SPIO nanoparticles. , 2008, General physiology and biophysics.

[33]  M. Pomper,et al.  11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase). , 2002, Molecular imaging.

[34]  K. Camphausen,et al.  Optical imaging of mice in oncologic research , 2004, Expert review of anticancer therapy.

[35]  C. Marosi,et al.  [11C] Methionine and [18F] Fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme , 2007, Journal of Neuro-Oncology.

[36]  J A Frank,et al.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Guilarte,et al.  Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS , 2005, Journal of NeuroVirology.

[38]  T. Meade,et al.  Rational design, synthesis, and biological evaluation of progesterone-modified MRI contrast agents. , 2007, Chemistry & biology.

[39]  Ralph Weissleder,et al.  Magnetic resonance and fluorescence based molecular imaging technologies. , 2005, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[40]  G L Brownell,et al.  A model for regional cerebral oxygen distribution during continuous inhalation of 15O2, C15O, and C15O2. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  J. Buscombe,et al.  Technetium-99m-Labelled Sulesomab (LeukoScan) in the Evaluation of Soft Tissue Infections , 2008, Medical Principles and Practice.

[42]  Koen Van Laere,et al.  Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain. , 2008, Current pharmaceutical design.

[43]  B. Oberg,et al.  Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. , 1991, Biochemical and biophysical research communications.

[44]  J. Best,et al.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.

[45]  Alan P. Koretsky,et al.  In vivo labeling of adult neural progenitors for MRI with micron sized particles of iron oxide: Quantification of labeled cell phenotype , 2009, NeuroImage.

[46]  T. Helbich,et al.  Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. , 2006, Radiology.

[47]  Mark Borden,et al.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.

[48]  Malini Olivo,et al.  In-vivo optical detection of cancer using chlorin e6 – polyvinylpyrrolidone induced fluorescence imaging and spectroscopy , 2009, BMC Medical Imaging.

[49]  Roland Hustinx,et al.  Imaging gliomas with positron emission tomography and single-photon emission computed tomography. , 2003, Seminars in nuclear medicine.

[50]  Jae Jeong,et al.  Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[51]  S. Gambhir,et al.  Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for Monitoring Reporter Gene Expression of Wild Type and Mutant Herpes Simplex Virus Type 1 Thymidine Kinase in Cell Culture , 2005, Molecular Imaging and Biology.

[52]  O. Schober,et al.  Assessment of therapy response by FDG PET in pediatric patients. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[53]  S. Shin,et al.  Tc-99m ciprofloxacin imaging in acute cholecystitis. , 2007, World journal of gastroenterology.

[54]  Alexander L. Klibanov,et al.  Microbubbles in ultrasound-triggered drug and gene delivery. , 2008, Advanced drug delivery reviews.

[55]  D. Perlman,et al.  Intrapatient Comparison of 2-Deoxy-2-[F-18]fluoro-d-glucose with Positron EmissionTomography/Computed Tomography to Tc-99m Fanolesomab (NeutroSpec) for Localization of Infection , 2007, Molecular Imaging and Biology.

[56]  A. Alavi,et al.  18F-FDG PET in Detecting Primary Breast Cancer , 2007, Journal of Nuclear Medicine.

[57]  M. Harisinghani,et al.  The potential of nanoparticle-enhanced imaging. , 2008, Urologic oncology.

[58]  C. Rowe,et al.  Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism , 2008, The Lancet Neurology.

[59]  H. Hanaoka,et al.  PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients , 2006, International Journal of Clinical Oncology.

[60]  C. Chung,et al.  Efficient labeling of mesenchymal stem cells using cell permeable magnetic nanoparticles. , 2009, Biochemical and biophysical research communications.

[61]  A. Alavi,et al.  Clinical applications of fluorodeoxyglucose-positron emission tomography in the management of malignant melanoma , 2005, Current opinion in oncology.

[62]  David A Mankoff,et al.  A definition of molecular imaging. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[63]  J. Humm,et al.  Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. , 1998, Cancer research.

[64]  E. Racker.  History of the Pasteur effect and its pathobiology , 1974, Molecular and Cellular Biochemistry.

[65]  David A Mankoff,et al.  FDG PET, PET/CT, and breast cancer imaging. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[66]  Sungeun Kim,et al.  11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[67]  C. Love,et al.  Radionuclide imaging of infection. , 2004, Journal of nuclear medicine technology.

[68]  T. Wensel,et al.  Rhodopsin–EGFP knock-ins for imaging quantal gene alterations , 2005, Vision Research.

[69]  Bonnie F. Sloane,et al.  Fluorescent Imaging of Tumors , 2007 .

[70]  K. Kinzler,et al.  Imaging of Musculoskeletal Bacterial Infections by [124I]FIAU-PET/CT , 2007, PloS one.

[71]  E. Malveaux,et al.  Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection. , 2002, Journal of medicinal chemistry.

[72]  M. Braddock.  Safely slowing down the decline in Alzheimer’s disease: gene therapy shows potential , 2005, Expert opinion on investigational drugs.

[73]  D. Wareham,et al.  Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton) , 2002, Journal of clinical pathology.

[74]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[75]  V. Ponomarev,et al.  A Human-Derived Reporter Gene for Noninvasive Imaging in Humans: Mitochondrial Thymidine Kinase Type 2 , 2007, Journal of Nuclear Medicine.

[76]  A. Leroy-Willig,et al.  Nuclear Magnetic Resonance Imaging and Spectroscopy , 2007 .

[77]  A. Pavlick,et al.  Whole body PET/CT for initial staging of choroidal melanoma , 2005, British Journal of Ophthalmology.

[78]  Xiaoping Hu,et al.  MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter , 2008, Magnetic resonance in medicine.

[79]  Heather Kalish,et al.  Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. , 2004, Blood.

[80]  Jeffrey A. James,et al.  Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.

[81]  R. Knight,et al.  Paramagnetic effects of iron(III) species on nuclear magnetic relaxation of fluid protons in porous media. , 2000, Journal of magnetic resonance.

[82]  A. Shields,et al.  In vivo imaging of cancer therapy , 2007 .

[83]  R. Coleman,et al.  Positron emission tomography imaging of brain tumors. , 2002, Neuroimaging clinics of North America.

[84]  N. Altorki,et al.  Current state of imaging for lung cancer staging. , 2004, Thoracic surgery clinics.

[85]  S. DeKosky,et al.  Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[86]  Markus Schwaiger,et al.  [18F]Galacto-RGD Positron Emission Tomography for Imaging of αvβ3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck , 2007, Clinical Cancer Research.

[87]  Wei Chen,et al.  Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  S. Libutti,et al.  Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[89]  O. Schober,et al.  Small animal PET in preclinical studies: opportunities and challenges. , 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[90]  A. Klibanov.  Ultrasound molecular imaging with targeted microbubble contrast agents , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[91]  A. Gee,et al.  Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils* , 2005, Journal of Biological Chemistry.

[92]  J. Sherley,et al.  Regulation of human thymidine kinase during the cell cycle. , 1988, The Journal of biological chemistry.

[93]  Paul A Dayton,et al.  Molecular ultrasound imaging using microbubble contrast agents. , 2007, Frontiers in bioscience : a journal and virtual library.

[94]  O. Witte,et al.  Positron emission tomography with injection of methionine as a prognostic factor in glioma. , 2001, Journal of neurosurgery.

[95]  K Wienhard,et al.  F-Dopa as an amino acid tracer to detect brain tumors. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[96]  Neal Rosen,et al.  Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors , 2004, Nature Biotechnology.

[97]  K. Laere,et al.  99mTc-Ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[98]  I. Kanno,et al.  Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[99]  G. Reifenberger,et al.  18F-FET PET differentiation of ring-enhancing brain lesions. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[100]  P. Langen,et al.  3'-Deoxy-3'-fluorothymidine, a new selective inhibitor of DNA-synthesis. , 1969, Acta biologica et medica Germanica.

[101]  G. Small,et al.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[102]  L. Specht,et al.  PET/CT in the management of haematological malignancies , 2008, European journal of haematology.

[103]  Richard E Carson,et al.  Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[104]  R. Ewers,et al.  Uptake of 18F-FLT and 18F-FDG in primary head and neck cancer correlates with survival , 2008, Nuklearmedizin.

[105]  Sylvain Houle,et al.  Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography , 2006, Journal of neurochemistry.

[106]  R. Weissleder,et al.  In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. , 2003, Cancer research.

[107]  M. López-Lázaro,et al.  The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? , 2008, Anti-cancer agents in medicinal chemistry.

[108]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[109]  Takashi Tsukamoto,et al.  High-affinity Near-infrared Fluorescent Small-molecule Contrast Agents for In Vivo Imaging of Prostate-specific Membrane Antigen , 2005, Molecular imaging.

[110]  D. Baumann,et al.  Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation , 2003, Magnetic Resonance in Medicine.

[111]  R. Blasberg,et al.  Imaging the expression of transfected genes in vivo. , 1995, Cancer research.

[112]  L. Josephson,et al.  The effects of iron oxides on proton relaxivity. , 1988, Magnetic resonance imaging.

[113]  E. Johansson,et al.  Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. , 2008, Journal of molecular biology.

[114]  C. Rowe,et al.  Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease , 2008, Neuropsychologia.

[115]  H. Kung,et al.  F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. , 2005, Nuclear medicine and biology.

[116]  M. Ide.  Cancer screening with FDG-PET. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[117]  Marvin Bergsneider,et al.  Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[118]  A. Luciani,et al.  Whole body MRI and PET/CT in haematological malignancies , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.

[119]  G. Johnson,et al.  In vivo small-animal imaging using micro-CT and digital subtraction angiography , 2008, Physics in medicine and biology.

[120]  S. DeKosky,et al.  Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[121]  A. van Waarde,et al.  Proliferation markers for the differential diagnosis of tumor and inflammation. , 2008, Current pharmaceutical design.

[122]  M. Halaç,et al.  Usefulness of 99mTc-ciprofloxacin (infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[123]  Y Zhang,et al.  Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. , 2000, Kidney international.

[124]  R. Coleman,et al.  Recommendations on the Use of 18F-FDG PET in Oncology , 2008, Journal of Nuclear Medicine.

[125]  R. Tiling,et al.  FDG-PET and FDG-PET/CT in breast cancer. , 2008, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[126]  L. Adler,et al.  F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging. , 2007, Radiologic clinics of North America.

[127]  S. Shousha,et al.  Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. , 2005, Cancer research.

[128]  H. Kung,et al.  Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for beta-amyloid plaque detection. , 2007, Bioorganic & medicinal chemistry letters.

[129]  Alan A. Wilson,et al.  In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[130]  R. Blasberg,et al.  Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging. , 2003, Neoplasia.

[131]  V. Ntziachristos,et al.  Textbook of in vivo imaging in vertebrates , 2006 .

[132]  K. Herfarth,et al.  Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-α-methyl-L-tyrosine and 99mTc-MIBI SPET , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[133]  Simon R Cherry,et al.  Small-animal preclinical nuclear medicine instrumentation and methodology. , 2008, Seminars in nuclear medicine.

[134]  Matthias Stuber,et al.  Positive contrast visualization of iron oxide‐labeled stem cells using inversion‐recovery with ON‐resonant water suppression (IRON) , 2007, Magnetic resonance in medicine.

[135]  E. Pakos,et al.  Use of 99mTc-Sulesomab for the Diagnosis of Prosthesis Infection after Total Joint Arthroplasty , 2007 .

[136]  Nicholas J Long,et al.  Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. , 2008, Angewandte Chemie.

[137]  M. Steinling,et al.  Comparison between Leukoscan (Sulesomab) and Gallium-67 for the diagnosis of osteomyelitis in the diabetic foot. , 2005, Diabetes & metabolism.

[138]  Vasilis Ntziachristos,et al.  Tomographic fluorescence imaging of tumor vascular volume in mice. , 2007, Radiology.

[139]  Sung-Cheng Huang,et al.  2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[140]  Alan A. Wilson,et al.  11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease. , 2003, Nuclear medicine and biology.

[141]  Koen Van Laere,et al.  Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[142]  Ralph Weissleder,et al.  Simultaneous fluorescence imaging of protease expression and vascularity during murine colonoscopy for colonic lesion characterization. , 2006, Gastrointestinal endoscopy.

[143]  H. Ashrafian.  Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis , 2006, The Lancet.

[144]  C. Jack,et al.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.

[145]  Gerald Antoch,et al.  False-Positive FDG PET Uptake−the Role of PET/CT , 2006, European Radiology.

[146]  Roman K. Thomas,et al.  Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[18F]-Fluoro-L-Thymidine ([18F]FLT) Positron Emission Tomography (PET) , 2008, PloS one.

[147]  R. Coleman,et al.  Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. , 2003, Radiology.

[148]  Keara M. Lane,et al.  Mouse models of human non-small-cell lung cancer: raising the bar. , 2005, Cold Spring Harbor symposia on quantitative biology.

[149]  Sophie Laurent,et al.  Contrast agents: magnetic resonance. , 2008, Handbook of experimental pharmacology.

[150]  A. Drzezga,et al.  Development and evaluation of compounds for imaging of β-amyloid plaque by means of positron emission tomography , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[151]  Stefano Fanti,et al.  18F-DOPA PET and PET/CT , 2007, Journal of Nuclear Medicine.

[152]  Steven G Potkin,et al.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.

[153]  Kiralee M. Hayashi,et al.  Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease , 2010, Neurobiology of Aging.

[154]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[155]  G Jakse,et al.  Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. , 1996, The Journal of urology.

[156]  L. Cinotti,et al.  High and Low Grade Oligodendrogliomas (ODG): Correlation of Amino-Acid and Glucose Uptakes Using PET and Histological Classifications , 2004, Journal of Neuro-Oncology.

[157]  M. Funke,et al.  Bildgebende Diagnostik des Mammakarzinoms , 2008, Der Radiologe.

[158]  Valerie A Longo,et al.  Dynamic Small-Animal PET Imaging of Tumor Proliferation with 3′-Deoxy-3′-18F-Fluorothymidine in a Genetically Engineered Mouse Model of High-Grade Gliomas , 2008, Journal of Nuclear Medicine.

[159]  W. Klunk,et al.  Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. , 2001, Life sciences.

[160]  B. Munch‐Petersen,et al.  Human thymidine kinase 1. Regulation in normal and malignant cells. , 1995, Advances in enzyme regulation.

[161]  J. Votaw,et al.  Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[162]  D. Mankoff,et al.  Current and Future Use of Positron Emission Tomography (PET) in Breast Cancer , 2006, Journal of Mammary Gland Biology and Neoplasia.

[163]  Falko Fend,et al.  Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma , 2007, Clinical Cancer Research.

[164]  B. Garner,et al.  Importance of Animal Models in Schizophrenia Research , 2005 .

[165]  D. Slattery,et al.  Animal models of mood disorders: recent developments , 2007, Current opinion in psychiatry.

[166]  Nadia Harbeck,et al.  Patterns of αvβ3 Expression in Primary and Metastatic Human Breast Cancer as Shown by 18F-Galacto-RGD PET , 2008, Journal of Nuclear Medicine.

[167]  M. Tuszynski,et al.  Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. , 2004, Progress in brain research.

[168]  Ming-Rong Zhang,et al.  Cerebral acetylcholinesterase imaging: development of the radioprobes. , 2007, Current topics in medicinal chemistry.

[169]  D. Weber,et al.  Ultra-high-resolution imaging of small animals: Implications for preclinical and research studies , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[170]  A. Maldonado,et al.  PET-CT in clinical oncology , 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[171]  C. Nanni,et al.  Positron-emission tomography in imaging and staging prostate cancer. , 2008, Cancer biomarkers : section A of Disease markers.

[172]  D. Bonekamp,et al.  Avid FDG uptake in a rapidly enlarging common carotid artery mycotic aneurysm, mimicking lymphadenopathy , 2009, Emergency Radiology.

[173]  F. Collins,et al.  A vision for the future of genomics research , 2003, Nature.

[174]  O. Muzik,et al.  Biodistribution, PET, and Radiation Dosimetry Estimates of HSV-tk Gene Expression Imaging Agent 1-(2′-Deoxy-2′-18F-Fluoro-β-d-Arabinofuranosyl)-5-Iodouracil in Normal Dogs , 2007, Journal of Nuclear Medicine.

[175]  S. Tanada,et al.  11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET , 2003, Nuclear medicine communications.

[176]  C. Love,et al.  Imaging of infection and inflammation with 99mTc-Fanolesomab. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[177]  Tomio Inoue,et al.  PET imaging of musculoskeletal tumours with fluorine-18 α-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET , 2000, European Journal of Nuclear Medicine.

[178]  R. Weissleder,et al.  Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. , 2001, Optics letters.

[179]  B. Branstetter,et al.  Indications for PET/CT in the head and neck. , 2008, Otolaryngologic clinics of North America.

[180]  Paul Maruff,et al.  β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .

[181]  V. Pike,et al.  Lipophilic analogs of thioflavin S as novel amyloid-imaging agents. , 2006, Current Alzheimer research.

[182]  Habib Zaidi,et al.  PET versus SPECT: strengths, limitations and challenges , 2008, Nuclear medicine communications.

[183]  C. Thompson,et al.  Cancer's sweet tooth. , 2006, Cancer cell.

[184]  Marvin D Nelson,et al.  Micro-MRI at 11.7 T of a murine brain tumor model using delayed contrast enhancement. , 2003, Molecular imaging.

[185]  J. Poirier.  Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer’s disease , 2008, Alzheimer's & Dementia.

[186]  Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography , 2009 .

[187]  B. Miller,et al.  11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration , 2007, Neurology.

[188]  T. Manabe,et al.  Evaluation of Primary Brain Tumors With FLT-PET: Usefulness and Limitations , 2006, Clinical nuclear medicine.

[189]  Michael V. Green,et al.  PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[190]  A. Darzi,et al.  Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. , 2006, The Lancet. Oncology.

[191]  K. Nichols,et al.  Diagnosing prosthetic vascular graft infection with the antigranulocyte antibody 99mTc-fanolesomab , 2006, Nuclear medicine communications.

[192]  R. Dierckx,et al.  PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. , 2008, Current pharmaceutical design.

[193]  K. Iyengar,et al.  Role of 99mTc Sulesomab in the diagnosis of prosthetic joint infections , 2005, Nuclear medicine communications.